Schedule 13D ownership disclosure

THERAVANCE INC

Security class unavailable · CUSIP: 88338T104

Event date: 2014-11-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
31,581,179
Percent of class
27.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-14-000568
Form type
SC 13D/A
Filer
GSK plc
CIK
CIK 1131399
Filed
Nov 04, 2014
Reporting period
Nov 04, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub